High-altitude retinopathy

Am J Ophthalmol. 1997 Mar;123(3):418-20. doi: 10.1016/s0002-9394(14)70149-7.

Abstract

Purpose: To report a patient with high-altitude retinopathy.

Methods: A 30-year-old man with high-altitude retinopathy was examined and treated.

Results: After spending 2 weeks at an altitude of 7,000 meters and then descending to sea level, the patient's visual acuity was RE, 20/20 and LE, 20/50. Intraretinal hemorrhages in both eyes and a scotoma in the left eye were found. Blood cell count was normal, but hematocrit had increased to 53%. The patient was treated with isovolemic hemodilution, pentoxifylline, and aspirin, which reduced hematocrit to 41%. Visual acuity and visual field returned to normal, and intraretinal hemorrhages resolved.

Conclusions: High-altitude hemoconcentration should be treated in patients with high-altitude retinopathy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Altitude Sickness / complications*
  • Altitude Sickness / therapy
  • Aspirin / therapeutic use
  • Blood Cell Count
  • Fluorescein Angiography
  • Fundus Oculi
  • Hematocrit
  • Hemodilution
  • Humans
  • Male
  • Pentoxifylline / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Retinal Hemorrhage / etiology*
  • Retinal Hemorrhage / therapy
  • Scotoma / etiology*
  • Scotoma / therapy
  • Vasodilator Agents / therapeutic use
  • Visual Acuity

Substances

  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
  • Aspirin
  • Pentoxifylline